Skip to main content
Clinical Trials/NCT04972266
NCT04972266CompletedNot Applicable

European Hypotension Prediction Index Real World Experience Using AcumenTM Hypotension Prediction Index Software to Prevent Intraoperative Hypotension: the Multicentre Prospective Observational Registry

Edwards Lifesciences12 sites in 5 countries702 target enrollmentStarted: September 28, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
702
Locations
12
Primary Endpoint
To describe the time-weighted average (TWA) mean arterial pressure (MAP) <65 mmHg when using AcumenTM Hypotension Prediction Index software

Study Overview

Brief Summary

European, multicenter, prospective, observational registry in patients undergoing elective major non-cardiac surgery

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Consenting adult patients (≥18 years)
  • Patient is scheduled for elective major non-cardiac surgery under general anesthesia that is expected to last at least 120 minutes and in whom blood pressure is monitored using an arterial catheter
  • Patients in whom the AcumenTM Hypotension Prediction Index software with the Acumen IQ sensor on the Hemosphere platform is used intraoperatively

Exclusion Criteria

  • Patients undergoing emergency surgery OR nephrectomy, liver and/or kidney transplantation
  • Patients suffering from atrial fibrillation and/or sepsis (according to current Sepsis-3 definition)
  • American Society of Anesthesiology (ASA) physical status classification V or VI
  • Disability and/or other circumstances under which the patient is not able to understand the nature, significance and scope of the investigation
  • Pregnancy at the time of surgery
  • Patients without signed informed consent / data protection statement
  • Patient participating in other interventional trials

Outcomes

Primary Outcomes

To describe the time-weighted average (TWA) mean arterial pressure (MAP) <65 mmHg when using AcumenTM Hypotension Prediction Index software

Time Frame: Duration of the procedure through 30 days after procedure

To describe the time-weighted average (TWA) mean arterial pressure (MAP) \<65 mmHg when using AcumenTM Hypotension Prediction Index software

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Edwards Lifesciences
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (12)

Loading locations...

Similar Trials